Last Updated

02 Dec 2019

Adjunctive Ivermectin Mass Drug Administration for Malaria Control: A cluster randomised placebo-controlled trial (MATAMAL)

Objectives

The main goal of this project is to investigate the impact of mass drug administration (MDA) with ivermectin on malaria transmission in a low-transmission setting. 

All the islands will be given the standard control tools, such as bed nets. The "intervention" islands will also be given the drug, whereas the "control" islands, will not.

Principal Investigator
Funding Information
Joint Global Health Trial Scheme
Study Design

Phase 3 trial

Primary outcome: Population-based Plasmodium falciparum prevalence (all ages)